Wolverine 10mg

Description

Composition: BPC-157 (5 mg), TB-500 (5 mg) — Total 10 mg

The Wolverine blend combines two of the most extensively researched tissue-repair peptides into a single precision formulation. Designed for accelerated structural recovery and systemic inflammation reduction, each component targets complementary pathways to produce a comprehensive healing response.

Mechanism of Action:

• BPC-157 → Stimulates angiogenesis via VEGF upregulation and nitric oxide pathways; enhances fibroblast migration and collagen deposition.
• TB-500 → Promotes actin polymerization and cellular migration; accelerates wound closure and reduces pro-inflammatory cytokines.

Together, these peptides address vascular repair and structural tissue recovery simultaneously for a full-spectrum regenerative response.

Research Highlights:

Preclinical studies demonstrate accelerated healing of muscle, tendon, ligament, and nerve tissue. Combined BPC-157/TB-500 protocols show superior recovery rates compared to either compound in isolation across multiple injury models.

References: PMID 26509918 | J Orthop Res 2020 | Curr Neuropharmacol 2021

Potential Applications (for research use):

• Musculoskeletal and tendon repair models
• Post-surgical and inflammatory injury research
• Nerve regeneration and vascular healing studies

Stacking Callouts:

Pairs well with KLOW for broader regenerative coverage, or NAD⁺ for cellular energy optimization during recovery models.

For laboratory and research use only. Not for human consumption.